Efficacy of GZR/EBR in Early Chronic Hepatitis C in HIV/HCV Co-infected Patients

NCT02897596 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

62

Enrollment

OTHER

Sponsor class

Conditions

Hepatitis C
HIV

Interventions

DRUG: Grazoprevir 100 mg/d 8 weeks
DRUG: Elbasvir 50 mg/d 8 weeks
DRUG: Grazoprevir 100 mg/d 12 weeks
DRUG: Elbasvir 50 mg/d 12 weeks

Sponsor

Fundacion Clinic per a la Recerca Biomédica